PUMA BIOTECHNOLOGY, INC. (PBYI) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
PBYI currently has 50.8M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 5.18% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 50.8M shares outstanding |
51M | 0 |
| Nov 06, 2025 |
10-Q filing | 50.3M shares outstanding |
50M | 0 |
| Aug 07, 2025 |
10-Q filing | 49.7M shares outstanding |
50M | 0 |
| May 08, 2025 |
10-Q filing | 49.6M shares outstanding |
50M | 0 |
| Feb 27, 2025 |
10-K filing | 49.1M shares outstanding |
49M | 0 |
| Nov 07, 2024 |
10-Q filing | 49.0M shares outstanding |
49M | 0 |
| Aug 01, 2024 |
10-Q filing | 48.3M shares outstanding |
48M | 0 |
| May 02, 2024 |
10-Q filing | 48.2M shares outstanding |
48M | 0 |
| Feb 29, 2024 |
10-K filing | 47.6M shares outstanding |
48M | 0 |
| Nov 02, 2023 |
10-Q filing | 47.5M shares outstanding |
48M | 0 |
| Aug 03, 2023 |
10-Q filing | 46.8M shares outstanding |
47M | 620K |
| May 04, 2023 |
10-Q filing | 46.6M shares outstanding |
47M | 740K |
| Mar 02, 2023 |
10-K filing | 44.7M shares outstanding |
45M | 2.7M |
| Dec 13, 2022 |
8-K filing: Puma Biotechnology sold 568,181 shares of its common stock to Alan H. Auerbach for approximately $2.5 million, with a price of $4.40 per share. The private placement closed on December 12, 2022. ($2.5M proceeds) |
46M | 1.8M |
| Nov 03, 2022 |
10-Q filing | 45.6M shares outstanding |
46M | 1.8M |
| Aug 04, 2022 |
10-Q filing | 45.4M shares outstanding |
45M | 2M |
| Jul 25, 2022 |
S-3 filing: Puma Biotechnology, Inc. is offering up to 1,792,114 shares of common stock by the Selling Stockholder from time to time in one or more offerings. |
42M | 5.2M |
| May 05, 2022 |
10-Q filing | 42.2M shares outstanding |
42M | 3.4M |
| Mar 14, 2022 |
8-K filing: Puma Biotechnology sold 3,584,228 shares of its common stock to Alan Auerbach and Athyrium Opportunities IV Co-Invest 2 LP for gross proceeds of $10.0 million in a private placement that closed on March 10, 2022. ($10.0M proceeds) |
40M | 5.5M |
| Mar 03, 2022 |
10-K filing | 40.1M shares outstanding |
40M | 5.5M |
| Nov 04, 2021 |
10-Q filing | 40.8M shares outstanding |
41M | 4.8M |
| Aug 05, 2021 |
10-Q filing | 40.5M shares outstanding |
40M | 5.1M |
| Jul 02, 2021 |
S-3 filing: Puma Biotechnology, Inc. files an S-3 form to offer and sell up to $50,000,000 in the aggregate of common stock from time to time in one or more offerings. |
40M | 5.3M |
| May 06, 2021 |
10-Q filing | 40.3M shares outstanding |
40M | 0 |
| Mar 01, 2021 |
10-K filing | 39.3M shares outstanding |
39M | 0 |
| Nov 05, 2020 |
10-Q filing | 39.7M shares outstanding |
40M | 0 |
| Aug 06, 2020 |
10-Q filing | 39.4M shares outstanding |
39M | 0 |
| May 07, 2020 |
10-Q filing | 39.4M shares outstanding |
39M | 0 |
| Feb 28, 2020 |
10-K filing | 39.3M shares outstanding |
39M | 0 |